Bryan Phillips, PA
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (42.1%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Gilead accounts for 86.4% of it on its own, with 8 other manufacturers making up the rest. 2025 is the largest year on record at $3,811, more than ten times the $77 reported in 2021. Among medical clinicians in ND with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 49 payments — averaging $90.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$4K
- Melinta Therapeutics, LLC$326
- AbbVie$117
- Kerecis Limited$46
- Ferring Pharmaceuticals Inc.$37
- Amgen$25
- plus $49 from 3 others
What the payments were for
- Consulting fees$1,86042%
- Travel & lodging$1,48034%
- Food & beverage$1,07424%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 18 | $3,814 |
| Melinta Therapeutics, LLC | 17 | $326 |
| AbbVie | 6 | $117 |
| Kerecis Limited | 2 | $46 |
| Ferring Pharmaceuticals Inc. | 2 | $37 |
| Amgen | 1 | $25 |
| Aimmune Therapeutics, Inc. | 1 | $20 |
| Merck | 1 | $19 |
| Echosens North America, Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Epclusa$3,327
How this compares
$4,414 in reported general payments places this provider in the 95th percentile of 51 medical providers in North Dakota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cefadroxil | 16 | $227 |
| Doxycycline Hyclate | 15 | $224 |
| Levofloxacin | 12 | $210 |
Paid to pharmacies, not to this prescriber.
Other medical in Minot
- Lori DockterMinot$3K
- Ginger StrandMinot$843
- Lindsey BakerMinot$176
- Shawn ThompsonMinot$81
- Abir OliverMinot$63
- Keri WeickMinot$60
- Christopher SeilMinot$31
- Mariah NathanMinot$15
- Gregory BjorklundFargo$47K
- Kayla OlsonGrand Forks$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.